Augmedix (NASDAQ:AUGX) vs. Medical Cannabis Payment Solutions (OTCMKTS:REFG) Critical Contrast

Augmedix (NASDAQ:AUGX) and Medical Cannabis Payment Solutions (OTCMKTS:REFG) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

Profitability

This table compares Augmedix and Medical Cannabis Payment Solutions’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Augmedix	-46.23%	-182.36%	-43.21%
Medical Cannabis Payment Solutions	N/A	N/A	N/A

Valuation and Earnings

This table compares Augmedix and Medical Cannabis Payment Solutions”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Augmedix	$51.58 million	2.23	-$19.17 million	($0.43)	-5.47
Medical Cannabis Payment Solutions	$140,000.00	N/A	-$30,000.00	N/A	N/A

Medical Cannabis Payment Solutions has lower revenue, but higher earnings than Augmedix.

Risk & Volatility

Augmedix has a beta of -0.22, suggesting that its stock price is 122% less volatile than the S&P 500. Comparatively, Medical Cannabis Payment Solutions has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500.

Institutional and Insider Ownership

87.1% of Augmedix shares are held by institutional investors. 11.0% of Augmedix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Augmedix and Medical Cannabis Payment Solutions, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Augmedix	0	4	0	0	2.00
Medical Cannabis Payment Solutions	0	0	0	0	N/A

Augmedix currently has a consensus price target of $3.09, indicating a potential upside of 31.38%.

Summary

Medical Cannabis Payment Solutions beats Augmedix on 5 of the 8 factors compared between the two stocks.

About Augmedix

Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. Its platform offers Augmedix Live that provides synchronous medical note documentation and point of care support; Augmedix Go Assist that offers asynchronous medical documentation based upon previously recorded visits; Augmedix Prep that provides patient demographics, past medical history, medication changes and other points from the patient's health record; and Augmedix Go, an autonomous, ambient AI mobile software application that offers fully automated medical documentation based upon recorded visits. The company enables clinicians to access its applications through mobile devices, such as smartphones. It serves health systems and specialty groups. The company was founded in 2013 and is headquartered in San Francisco, California.

About Medical Cannabis Payment Solutions

Medical Cannabis Payment Solutions, Inc. develops and markets a payment system for medical cannabis transactions. Its solution assists in the state tracking of sales, collection of tax, and supervision of sales to consumers. The company was incorporated in 2013 and is based in Cheyenne, Wyoming.